Table 2 Immunologic and virologic parameters of patients that were selected for the study.
Patient | Timepoint (years from infection) | HIVRNA copies/ml of plasma | CD4+ T cell counts/mm3 |
|---|---|---|---|
A | I (9) | 28000 | 561 |
| Â | II(11) | 32360 | 379 |
| Â | III(13) | 127200 | 337 |
B | I (8.5) | 25000 | 374 |
| Â | II(9.5) | 65000 | 255 |
| Â | III(10.5) | 40000 | 259 |
C | I(10) | 99 | 1144 |
| Â | II(11) | 100 | 944 |
| Â | III(12) | 549 | 776 |
D | I(9.5) | 2918 | 993 |
| Â | II(10.5) | 3318 | 735 |
| Â | III(12) | 6850 | 640 |
E | I(11.5) | 1200 | 795 |
| Â | II(12.5) | 2000 | 720 |
| Â | III(13.2) | 3034 | 527 |
F | I(8) | 2100 | 645 |
| Â | II(10) | 1200 | 657 |
| Â | III(13) | 6393 | 625 |
G | I(10) | 560 | 864 |
| Â | II(13) | 106 | 926 |
| Â | III(14) | 152 | 750 |